Anticoagulant antidote works Beyond statins: What you need to know about alternative lipid-lowering agents Wrist-worn heart monitors not always accurate Validation ‘imperative’ for serious clinical use, researchers say Case Report: A patient with familial dyslipidemia fails to respond to statins Got patients with a-fib? You need to read this Recent studies evaluate biomarkers for risk assessment and compare oral anticoagulants Pharmacist-directed dyslipidemia care improves cholesterol management Pharmacist prescribing and monitoring of lipid-lowering therapy enables more patients with uncontrolled dyslipidemia to reach LDL-C targets. A heart attack is hard on younger patients’ sex life Women suffer more than men in the year after an acute MI, study finds Psoriasis and heart disease: ‘Major educational efforts’ needed Coronary arteries in just as bad a shape as those in type 2 diabetes patients Patient doing well on warfarin? Check again Stability is elusive for patients on long-term anticoagulation 2016 Canadian dyslipidemia guidelines Despite controversy, experts continue to recommend LDL-C targets for patients started on lipid-lowering therapy. First Previous 37 38 39 40 41 Next Last
